Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ward, J.
Right arrow Articles by Robinson, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ward, J.
Right arrow Articles by Robinson, P. J.
(Radiology. 2000;216:154-162.)
© RSNA, 2000


Gastrointestinal Imaging

Hepatocellular Carcinoma in the Cirrhotic Liver: Double-Contrast MR Imaging for Diagnosis1

Janice Ward, MSc, DCR, James A. Guthrie, MRCP, FRCR, David J. Scott, FRCR, Julian Atchley, FRCR, Daniel Wilson, MSc, Mervyn H. Davies, MD, FRCP, Judith I. Wyatt, MRCPath, MB, ChB and Philip J. Robinson, FRCP, FRCR

1 From the Departments of Radiology, MRI Unit (J.W., J.A.G., D.J.S., J.A., P.J.R.), Medical Physics (D.W.), Hepatology (M.H.D.), and Pathology (J.I.W.), St James's University Hospital, Beckett Street, Leeds LS9 7TF, United Kingdom. From the 1999 RSNA scientific assembly. Received August 13, 1999; revision requested October 7; revision received November 1; accepted November 10. Address correspondence to J.W. (e-mail: Janice.Ward@gw.sjsuh.northy.nhs.uk).

PURPOSE: To measure the sensitivity and accuracy of double-contrast magnetic resonance (MR) imaging for the diagnosis of hepatocellular carcinoma (HCC) in the cirrhotic liver.

MATERIALS AND METHODS: Twenty-seven patients with MR features of dysplastic nodules and/or HCC were examined. T2-weighted spin-echo and T1-weighted gradient-echo imaging was performed before and after superparamagnetic iron oxide (SPIO) administration and immediately followed by T1-weighted gradient-echo imaging at 10, 40, and 120 seconds after bolus injection of a gadolinium-based contrast material. Nonenhanced, nonenhanced plus SPIO-enhanced, and nonenhanced plus SPIO-enhanced plus gadolinium-enhanced images were reviewed. Alternative–free response receiver operating characteristic (ROC) methodology was used to analyze the results, which were correlated with histopathologic findings after transplantation in 15 patients and at biopsy in 12. Lesions visualized with all three techniques were characterized as a dysplastic nodule or HCC, and ROC analysis was performed.

RESULTS: For all observers, SPIO-enhanced MR imaging (mean accuracy, 0.76) was more accurate than nonenhanced MR imaging (mean accuracy, 0.64) (P < .04), and double-contrast MR imaging (mean accuracy, 0.86) was more accurate than SPIO-enhanced imaging (P < .05). Both types of lesions were correctly characterized with all three techniques, although observer confidence for lesion characterization was greatest with double-contrast MR imaging.

CONCLUSION: Double-contrast MR imaging significantly improves the diagnosis of HCC compared with SPIO-enhanced and nonenhanced imaging (P < .01).

Index terms: Gadolinium • Iron • Liver neoplasms, 761.31, 761.323 • Liver neoplasms, MR, 761.121411, 761.121412, 761.121416, 761.12143 • Magnetic resonance (MR), comparative studies, 761.121411, 761.121412, 761.121416, 761.12143 • Magnetic resonance (MR), contrast enhancement, 761.12143 • Magnetic resonance (MR), contrast media, 761.12143




This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
Y K KIM, C S KIM, and Y M HAN
Detection of small hepatocellular carcinoma: comparison of conventional gadolinium-enhanced MRI with gadolinium-enhanced MRI after the administration of ferucarbotran
Br. J. Radiol., June 1, 2009; 82(978): 468 - 484.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. M. Willatt, H. K. Hussain, S. Adusumilli, and J. A. Marrero
MR Imaging of Hepatocellular Carcinoma in the Cirrhotic Liver: Challenges and Controversies
Radiology, May 1, 2008; 247(2): 311 - 330.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
R. F. Hanna, D. A. Aguirre, N. Kased, S. C. Emery, M. R. Peterson, and C. B. Sirlin
Cirrhosis-associated Hepatocellular Nodules: Correlation of Histopathologic and MR Imaging Features
RadioGraphics, May 1, 2008; 28(3): 747 - 769.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
R. F. Hanna, N. Kased, S. W. Kwan, A. C. Gamst, A. C. Santosa, T. Hassanein, and C. B. Sirlin
Double-Contrast MRI for Accurate Staging of Hepatocellular Carcinoma in Patients with Cirrhosis
Am. J. Roentgenol., January 1, 2008; 190(1): 47 - 57.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
S. N. Gandhi, M. A. Brown, J. G. Wong, D. A. Aguirre, and C. B. Sirlin
MR Contrast Agents for Liver Imaging: What, When, How
RadioGraphics, November 1, 2006; 26(6): 1621 - 1636.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
A. M. Lutz, J. K. Willmann, K. Goepfert, B. Marincek, and D. Weishaupt
Hepatocellular Carcinoma in Cirrhosis: Enhancement Patterns at Dynamic Gadolinium- and Superparamagnetic Iron Oxide-enhanced T1-weighted MR Imaging
Radiology, November 1, 2005; 237(2): 520 - 528.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
P J A Robinson
EBM and the diagnosis of hepatocellular carcinoma
Br. J. Radiol., April 1, 2005; 78(928): 370 - 371.
[Full Text] [PDF]


Home page
The OncologistHome page
D. V. Sahani and S. P. Kalva
Imaging the Liver
Oncologist, July 1, 2004; 9(4): 385 - 397.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. E. J. Pijl, J. Doornbos, M. N. J. M. Wasser, H. C. van Houwelingen, R. A. E. M. Tollenaar, and J. L. Bloem
Quantitative Analysis of Focal Masses at MR Imaging: A Plea for Standardization
Radiology, June 1, 2004; 231(3): 737 - 744.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
Y. K. Kim, C. S. Kim, Y. H. Lee, H. S. Kwak, and J. M. Lee
Comparison of Superparamagnetic Iron Oxide-Enhanced and Gadobenate Dimeglumine-Enhanced Dynamic MRI for Detection of Small Hepatocellular Carcinomas
Am. J. Roentgenol., May 1, 2004; 182(5): 1217 - 1223.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M.-J. Kim, J. H. Kim, J.-J. Chung, M. S. Park, J. S. Lim, and Y. T. Oh
Focal Hepatic Lesions: Detection and Characterization with Combination Gadolinium- and Superparamagnetic Iron Oxide-enhanced MR Imaging
Radiology, September 1, 2003; 228(3): 719 - 726.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. Ward, J. A. Guthrie, D. Wilson, P. Arnold, J. P. Lodge, G. J. Toogood, J. I. Wyatt, and P. J. Robinson
Colorectal Hepatic Metastases: Detection with SPIO-enhanced Breath-hold MR Imaging—Comparison of Optimized Sequences
Radiology, September 1, 2003; 228(3): 709 - 718.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
I. E. Steingruber, A. Mallouhi, B. V. Czermak, P. Waldenberger, E. Gassner, F. Offner, A. Chemelli, A. Koenigsrainer, W. Vogel, and W. R. Jaschke
Pretransplantation Evaluation of the Cirrhotic Liver with Explantation Correlation: Accuracy of CT Arterioportography and Digital Subtraction Hepatic Angiography in Revealing Hepatocellular Carcinoma
Am. J. Roentgenol., July 1, 2003; 181(1): 99 - 108.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
B. Bhartia, J. Ward, J. A. Guthrie, and P. J. Robinson
Hepatocellular Carcinoma in Cirrhotic Livers: Double-Contrast Thin-Section MR Imaging with Pathologic Correlation of Explanted Tissue
Am. J. Roentgenol., March 1, 2003; 180(3): 577 - 584.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
K. Mori, J. Scheidler, T. Helmberger, N. Holzknecht, R. Schauer, C. A. Schirren, I. Bittmann, M. Dugas, and M. Reiser
Detection of Malignant Hepatic Lesions Before Orthotopic Liver Transplantation: Accuracy of Ferumoxides-Enhanced MR Imaging
Am. J. Roentgenol., October 1, 2002; 179(4): 1045 - 1051.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. K. Kim, S. H. Kim, W. J. Lee, H. Kim, J. W. Seo, D. Choi, H. K. Lim, S. J. Lee, and J. H. Lim
Preoperative Detection of Hepatocellular Carcinoma: Ferumoxides-Enhanced Versus Mangafodipir Trisodium--Enhanced MR Imaging
Am. J. Roentgenol., September 1, 2002; 179(3): 741 - 750.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. S. Raman, D. S. K. Lu, S. C. Chen, J. Sayre, F. Eilber, and J. Economou
Hepatic MR Imaging Using Ferumoxides: Prospective Evaluation with Surgical and Intraoperative Sonographic Confirmation in 25 Cases
Am. J. Roentgenol., October 1, 2001; 177(4): 807 - 812.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
E. Caturelli, M. Pompili, F. Bartolucci, D. A. Siena, M. Sperandeo, A. Andriulli, and M. Bisceglia
Hemangioma-like Lesions in Chronic Liver Disease: Diagnostic Evaluation in Patients
Radiology, August 1, 2001; 220(2): 337 - 342.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
G. A. Krinsky, V. S. Lee, N. D. Theise, J. C. Weinreb, N. M. Rofsky, T. Diflo, and L. W. Teperman
Hepatocellular Carcinoma and Dysplastic Nodules in Patients with Cirrhosis: Prospective Diagnosis with MR Imaging and Explantation Correlation
Radiology, May 1, 2001; 219(2): 445 - 454.
[Abstract] [Full Text]


Home page
RadiologyHome page
D. Pauleit, J. Textor, R. Bachmann, R. Conrad, S. Flacke, G. Layer, B. Kreft, and H. Schild
Hepatocellular Carcinoma: Detection with Gadolinium- and Ferumoxides-enhanced MR Imaging of the Liver
Radiology, January 1, 2002; 222(1): 73 - 80.
[Abstract] [Full Text] [PDF]